Multi-Omics Analysis of Survival-Related Splicing Factors and Identifies CRNKL1 as a Therapeutic Target in Esophageal Cancer
Genes · 2025
DOI: 10.3390/genes16040379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Tianrui Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Cli…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, RNA Splicing Factors. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Provincial Natural Science Foundation of Guangdong and Guangdong Basic and Applied Basic Research Foundation, the Science Foundation of Army Medical University.
Abstract (Originalsprache)
Background
RNA alternative splicing represents a pivotal regulatory mechanism of eukaryotic gene expression, wherein splicing factors (SFs) serve as key regulators. Aberrant SF expression drives oncogenic splice variant production, thereby promoting tumorigenesis and malignant progression. However, the biological functions and potential targets of SFs remain largely underexplored.
Methods
Through multi-omics analysis, we identified survival-related splicing factors (SFs) in esophageal cancer and elucidated their biological regulatory networks. To further investigate their downstream splicing targets, we combined alternative splicing events resulting from SF knockdown with those specific to esophageal cancer. Finally, these splicing events were validated through full-length RNA sequencing and confirmed in cancer cells and clinical specimens.
Result
We identified six SFs that are highly expressed in esophageal cancer and correlate with poor prognosis. Further analysis revealed that these factors are significantly associated with immune infiltration, cancer stemness, tumor heterogeneity, and drug resistance. CRNKL1 was identified as a hub SFs. The target genes and pathways regulated by these SFs showed substantial overlap, suggesting their coordinated roles in promoting cancer stemness and metastasis. Specifically, alternative splicing of key markers, such as CD44 and CTTN, was regulated by most of these SFs and correlated with poor prognosis.
Conclusions
Our study unveils six survival-related SFs that contribute to the aggressiveness of esophageal cancer and CTTN and CD44 alternative splicing may act as common downstream effectors of survival-related SFs. This study provides mechanistic insights into SF-mediated tumorigenesis and highlight novel therapeutic vulnerabilities in esophageal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center…
- Department of Experimental Research, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
- Lab Teaching & Management Center, Institute of Life Science and Laboratory of Tissue and Cell Biology, Chongqing Medical University, Chongqing 400016, China.
- Department of Radiation Oncology, Guangzhou Concord Cancer Center, Guangzhou 510060, China.
- Department of Microbiology, Army Medical University, Chongqing 400038, China.
ORCID-Profile: Tianrui Gao, Bijun Huang
Förderung
- National Natural Science Foundation of China
- the Provincial Natural Science Foundation of Guangdong and Guangdong Basic and Applied Basic Research Foundation
- the Science Foundation of Army Medical University
- Provincial Natural Science Foundation of Guangdong and Guangdong Basic and Applied Basic Research Foundation, China
- Science Foundation of Army Medical University
Zitieren
APA
Gao, T., Fan, M., Zeng, Z., Peng, L., Qian, C. N., Zhao, X., & Huang, B. (2025). Multi-Omics Analysis of Survival-Related Splicing Factors and Identifies CRNKL1 as a Therapeutic Target in Esophageal Cancer. Genes. https://doi.org/10.3390/genes16040379
Vancouver
Gao T, Fan M, Zeng Z, Peng L, Qian CN, Zhao X, et al. Multi-Omics Analysis of Survival-Related Splicing Factors and Identifies CRNKL1 as a Therapeutic Target in Esophageal Cancer. Genes. 2025. doi:10.3390/genes16040379
BibTeX
@article{Gao2025,
author = {Gao, Tianrui and Fan, Meiling and Zeng, Zhongyuan and Peng, Lixia and Qian, Chao-Nan and Zhao, Xia and Huang, Bijun},
title = {Multi-Omics Analysis of Survival-Related Splicing Factors and Identifies CRNKL1 as a Therapeutic Target in Esophageal Cancer},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16040379}
}
EUVIMED